Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.
about
Gut microbiota role in irritable bowel syndrome: New therapeutic strategiesImpact of psychological stress on irritable bowel syndromeAdvances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotideMechanisms of pain from urinary tract infectionUpregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective rolesExperimental and computational evidence for an essential role of NaV1.6 in spike initiation at stretch-sensitive colorectal afferent endingsRisk for Irritable Bowel Syndrome in Fibromyalgia Patients: A National Database StudyEffects of NB001 and gabapentin on irritable bowel syndrome-induced behavioral anxiety and spontaneous pain.Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome.The role of mast cells in functional GI disorders.Arabinogalactan and fructo-oligosaccharides have a different fermentation profile in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME ®).Neural networks in intestinal immunoregulationMore negative self-esteem and inferior coping strategies among patients diagnosed with IBS compared with patients without IBS--a case-control study in primary care.Irritable bowel syndrome: the problem and the problem of treating it - is there a role for probiotics?Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome.Long-term upregulation of cortical glutamatergic AMPA receptors in a mouse model of chronic visceral pain.Altered colorectal afferent function associated with TNBS-induced visceral hypersensitivity in miceDescending pain modulation in irritable bowel syndrome (IBS): a systematic review and meta-analysis.Abdominal pain in ulcerative colitis.Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.Persistent Catechol-O-methyltransferase-dependent Pain Is Initiated by Peripheral β-Adrenergic ReceptorsDevelopmental Changes in Pain and Spinal Immune Gene Expression after Radicular Trauma in the Rat.Effects of DA-9701, a novel prokinetic agent, on phosphorylated extracellular signal-regulated kinase expression in the dorsal root ganglion and spinal cord induced by colorectal distension in ratsPathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia.New pharmacological treatment options for irritable bowel syndrome with constipation.Administration of Wasabia koreana Ameliorates Irritable Bowel Syndrome-Like Symptoms in a Zymosan-Induced Mouse Model.Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome.Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases.Activating transcription factor 4 modulates BDNF release from microglial cells.Activation of guanylate cyclase-C attenuates stretch responses and sensitization of mouse colorectal afferents.Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article.Ambroxol for the treatment of fibromyalgia: science or fiction?In vitro functional characterization of mouse colorectal afferent endings.Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity?The gut as a sensory organ.From Mechanism to Cure: Renewing the Goal to Eliminate the Disease of Pain.Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2.Risk for irritable bowel syndrome in fibromyalgia patients: a national database study.
P2860
Q26768550-3E164723-3B54-4331-91F9-276B93458DE2Q26853213-B033834C-7834-492D-A0FD-0C96F73DFB55Q26865304-09E0DFF8-5677-4BF6-A73A-04787B9DC9BCQ27028174-BB337DCD-B993-4391-A3F8-A12ABEE197FFQ27345472-1D528BEC-48C8-4D14-B13D-704102D0C351Q30646640-4B2FFEEF-9098-47EC-945B-4B82F4EEAAC8Q33621435-EB02C617-6004-4625-86BC-A5D89F9AECF2Q33807470-CE91210C-97C5-43D5-A485-02C84F0F7BD8Q34129435-8C5EB772-880E-4B18-B5FB-02AF80A8B366Q34346102-85389C07-00DC-473E-9C90-CCBCF8566922Q34486007-4E53D07A-3C25-4D05-9BB9-2A6286482DCCQ34830515-1811FCA2-5F2B-49F2-A524-ACCC4FA44683Q34836430-5A3EA9F9-7267-4BB5-AF83-966D4ECA15EEQ35048084-40C5A2B5-EF09-4F90-81F0-940A8B9E6FBFQ35231621-D3241950-ACDB-415C-B2BB-0518DCBE0F2DQ35590592-8AF1543C-B416-4609-9568-A1CAB9475F4CQ36301835-63E27F8C-BC40-4CBF-AEED-8CE8E09CEA15Q36312370-6CAE75E4-37A3-49AF-9FC9-DC532B0A7907Q36361432-C1CE363A-B479-41BC-AEC2-4FD5BAF45A6FQ37110178-CD4D9F9B-8FE9-47BD-9BB0-FDAC510B8E60Q37234770-2DADCF1F-F052-4220-A16D-AA45C722ED61Q37241501-AA2C6069-73A8-4D9B-87E8-D4DCABE47844Q37503843-AF6F083A-C2FD-4B0E-8962-13FCF1FDA637Q37660385-ABAA834C-5792-4961-A793-23215CD87A51Q37677017-3F84B2C1-4804-4802-BCEA-45E04EA1448EQ38240885-9402AE9E-8868-43CF-BCC1-4E38E7E38B85Q38628078-C5972FEB-3E88-436F-8897-21A3D5E70AD0Q38815136-42BD3DDF-E187-47F0-9EC6-5B3CAC06782CQ38981245-15A760B5-E709-415C-B007-249AA988DC30Q39012302-CDA180E3-9437-44FB-BAA8-E57094D81AB8Q39090741-02CE3363-C924-493D-9613-7C0B1A9CB1F5Q39143552-EAC2761D-1E43-4538-A49C-5EC18CA840D9Q41392745-2A95BC44-4FEC-4E71-85EF-A08FC6FF081DQ41483222-468FAD20-F301-41B5-AD8F-1192E923FFE3Q42029422-DDAD382F-6DCE-4A8B-8E9B-07AE87C2A136Q43420598-7EEDA613-CD9C-4ED6-97EB-F47D8C321F5BQ45894561-1D17421F-2300-4915-A627-0FECBADCEC50Q47566382-B6C2E94E-8BC4-4A19-9BD0-C37CF9BA30D7Q47746673-7B9B2462-D110-4A2D-974C-3112DE2D85C1Q51275594-E6961FBD-F883-4080-9EE5-4D369C47DE31
P2860
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Irritable bowel syndrome: meth ...... y in irritable bowel syndrome.
@ast
Irritable bowel syndrome: meth ...... y in irritable bowel syndrome.
@en
type
label
Irritable bowel syndrome: meth ...... y in irritable bowel syndrome.
@ast
Irritable bowel syndrome: meth ...... y in irritable bowel syndrome.
@en
prefLabel
Irritable bowel syndrome: meth ...... y in irritable bowel syndrome.
@ast
Irritable bowel syndrome: meth ...... y in irritable bowel syndrome.
@en
P2093
P2860
P356
P1476
Irritable bowel syndrome: meth ...... ty in irritable bowel syndrome
@en
P2093
Erica S Schwartz
G F Gebhart
P2860
P304
P356
10.1152/AJPGI.00542.2011
P50
P577
2012-03-08T00:00:00Z